S-100B Concentrations Predict Disease-Free Survival in Stage III Melanoma Patients

BACKGROUND: Elevation of the tumor marker S-100B in melanoma patients is a highly specific indicator of recurrence. MATERIALS AND METHODS: The role of S-100B in disease-free survival (DFS) was evaluated in stage III melanoma patients (staged with fluorodeoxyglucose positron emission tomography [FDG-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruijff, S., Bastiaannet, E., Muller Kobold, A. C., van Ginkel, R. J., Suurmeijer, A. J. H., Hoekstra, H. J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Melanomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779363/
https://www.ncbi.nlm.nih.gov/pubmed/19636631
http://dx.doi.org/10.1245/s10434-009-0629-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779363/
https://www.ncbi.nlm.nih.gov/pubmed/19636631
http://dx.doi.org/10.1245/s10434-009-0629-8

Ejemplares similares